Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2009-7-9
pubmed:abstractText
To investigate the benefits of long-term therapy with Xuezhikang, a cholestin extract, in combination with calcium channel blockers for improvement of left ventricular (LV) hypertrophy and function in patients with essential hypertension, as determined using echocardiography.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1557-7708
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
15
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
719-25
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:19552598-Aged, pubmed-meshheading:19552598-Biological Agents, pubmed-meshheading:19552598-Blood Flow Velocity, pubmed-meshheading:19552598-C-Reactive Protein, pubmed-meshheading:19552598-Calcium Channel Blockers, pubmed-meshheading:19552598-Case-Control Studies, pubmed-meshheading:19552598-Collagen Type I, pubmed-meshheading:19552598-Diastole, pubmed-meshheading:19552598-Drug Therapy, Combination, pubmed-meshheading:19552598-Drugs, Chinese Herbal, pubmed-meshheading:19552598-Female, pubmed-meshheading:19552598-Humans, pubmed-meshheading:19552598-Hypertension, pubmed-meshheading:19552598-Hypertrophy, Left Ventricular, pubmed-meshheading:19552598-Male, pubmed-meshheading:19552598-Middle Aged, pubmed-meshheading:19552598-Mitral Valve, pubmed-meshheading:19552598-Nifedipine, pubmed-meshheading:19552598-Single-Blind Method, pubmed-meshheading:19552598-Ventricular Dysfunction, Left
pubmed:year
2009
pubmed:articleTitle
Potential protective effect of long-term therapy with Xuezhikang on left ventricular diastolic function in patients with essential hypertension.
pubmed:affiliation
Department of Geriatric Cardiology, Chinese PLA General Hospital, Beijing, China. yeping301@yahoo.com.cn
pubmed:publicationType
Journal Article, Randomized Controlled Trial